Significant Increase in Radiology AI Authorizations
According to U.S. Food and Drug Administration data, the number of approvals for radiology artificial intelligence tools increased by over 40 percent between 2023 and 2025.
A new analysis of the U.S. Food and Drug Administration's medical device database has revealed the changing regulatory status and recent growth trend of AI-powered radiology tools.
Increase in FDA Data
According to the U.S. Food and Drug Administration database, the number of AI-powered radiology devices authorized by the agency has exceeded one thousand. AI applications have held a dominant position on the lists for a long time.
Research Details and Scope
A new analysis published in the journal Academic Radiology provides a valuable resource for organizations considering integrating the technology into their practices. Experts emphasize that the updated review is timely in terms of understanding the current situation.
Expert Evaluations
Dr. Stella K. Kang and colleagues from the radiology department at Columbia University Irving Medical Center noted that accurate characterization informs procurement and management decisions. It was also stated that this helps identify clinical areas requiring research.
Technological Distribution
The research team examined 1,094 radiology AI devices authorized by the FDA through December 2025 in terms of their functions, clinical applications, and manufacturers. During the reviewed period, annual authorizations increased by 42 percent while the overall functional structure remained relatively stable.